Minimal change disease

Gordillo R, Spitzer A. The nephrotic syndrome. Pediatr Rev. 2009;30:94-104. Abstract

Eddy AA, Symons JM. Nephrotic syndrome in childhood. Lancet. 2003 Aug 23;362(9384):629-39. Abstract

Shigidi MM. The treatment of relapse in adults with minimal change nephrotic syndrome: myths and facts. Saudi J Kidney Dis Transpl. 2011;22:10-17. Abstract

1. Gordillo R, Spitzer A. The nephrotic syndrome. Pediatr Rev. 2009;30:94-104. Abstract

2. Eddy AA, Symons JM. Nephrotic syndrome in childhood. Lancet. 2003 Aug 23;362(9384):629-39. Abstract

3. Schlesinger ER, Sultz HA, Mosher WE, et al. The nephrotic syndrome: its incidence and implications for the community. Am J Dis Child. 1968;116:623-632. Abstract

4. McKinney PA, Feltbower RG, Brocklebank JT, et al. Time trends and ethnic patterns of childhood nephrotic syndrome in Yorkshire, UK. Pediatr Nephrol. 2001;16:1040-1044. Abstract

5. Wong W. Idiopathic nephrotic syndrome in New Zealand children, demographic, clinical features, initial management and outcome after twelve-month follow-up: results of a three-year national surveillance study. J Paediatr Child Health. 2007;43:337-341. Abstract

6. Baqi N, Singh A, Balachandra S, et al. The paucity of minimal change disease in adolescents with primary nephrotic syndrome. Pediatr Nephrol. 1998;12:105-107. Abstract

7. Nie S, He W, Huang T, et al. The spectrum of biopsy-proven glomerular diseases among children in China: a national, cross-sectional survey. Clin J Am Soc Nephrol. 2018 Jul 6;13(7):1047-54.Full text  Abstract

8. Mesquita M, Fosso C, Bakoto Sol E, et al. Renal biopsy findings in Belgium: a retrospective single center analysis. Acta Clin Belg. 2011;66:104-109. Abstract

9. Su S, Yu J, Wang Y, et al. Clinicopathologic correlations of renal biopsy findings from northeast China: A 10-year retrospective study. Medicine (Baltimore). 2019 Jun;98(23):e15880.Full text  Abstract

10. Inguill E, Tejani A. Racial differences in the incidence and renal outcome of idiopathic focal segmental glomerulosclerosis in children. Pediatr Nephrol. 1991;5:393-397. Abstract

11. Andreoli SP. Racial and ethnic differences in the incidence and progression of focal segmental glomerulosclerosis in children. Adv Ren Replace Ther. 2004;11:105-109. Abstract

12. Bonilla-Felix M, Parra C, Dajani T, et al. Changing patterns in the histopathology of idiopathic nephrotic syndrome in children. Kidney Int. 1999;55:1885-1890.Full text  Abstract

13. International Study of Kidney Disease in Children. Nephrotic syndrome in children: prediction of histopathology from clinical and laboratory characteristics at time of diagnosis. A report of the International Study of Kidney Disease in Children. Kidney Int. 1978;13:159-165. Abstract

14. Filler G, Young E, Geier P, et al. Is there really an increase in non-minimal change nephrotic syndrome in children? Am J Kidney Dis. 2003;42:1107-1113. Abstract

15. Borges FF, Shiraichi L, da Silva MP, et al. Is focal segmental glomerulosclerosis increasing in patients with nephrotic syndrome? Pediatr Nephrol. 2007;22:1309-1313. Abstract

16. Boyer O, Moulder JK, Somers MJ. Focal and segmental glomerulosclerosis in chidlren: a longitudinal assessment. Pediatr Nephrol. 2007;22:1159-1166. Abstract

17. Vogt B. Nephrology update: glomerular disease in children. FP Essent. 2016;444:30-40. Abstract

18. Mathieson PW. Immune dysregulation in minimal change nephropathy. Nephrol Dial Transplant. 2003;18(suppl 6):vi26-vi29. Abstract

19. Audard V, Larousserie F, Grimbert P, et al. Minimal change nephrotic syndrome and classical Hodgkin's lymphoma: report of 21 cases and review of the literature. Kidney Int. 2006;69:2251-2260. Abstract

20. Aslam N, Nseir NI, Viverett JF, et al. Nephrotic syndrome in chronic lymphocytic leukemia: a paraneoplastic syndrome? Clin Nephrol. 2000;54:492-497. Abstract

21. Shalhoub RJ. Pathogenesis of lipoid nephrosis: a disorder of T-cell function. Lancet. 1974;2(7880):556-560. Abstract

22. Niaudet P. Genetic forms of nephrotic syndrome. Pediatr Nephrol. 2004;19:1313-1318. Abstract

23. Murugapandian S, Mansour I, Hudeeb M, et al. Epidemiology of glomerular disease in southern Arizona: review of 10-year renal biopsy data. Medicine (Baltimore). 2016;95:e3633.Full text  Abstract

24. Teeninga N, Schreuder MF, Bokenkamp A, et al. Influence of low birth weight on minimal change nephrotic syndrome in children, including a meta-analysis. Nephrol Dial Transplant. 2008;23:1615-1620.Full text  Abstract

25. Gipson DS, Massengill SF, Yao L, et al. Management of childhood onset nephrotic syndrome. Pediatrics. 2009;124:747-757. Abstract

26. Vivarelli M, Massella L, Ruggiero B, et al. Minimal change disease. Clin J Am Soc Nephrol. 2017 Feb 7;12(2):332-45.Full text  Abstract

27. Ehrich JH, Brodehl J. Long versus standard prednisone therapy for initial treatment of idiopathic nephrotic syndrome in children. Arbeitsgemeinschaft fur Padiatrische Nephrologie. Eur J Pediatr. 1993;152:357-361. Abstract

28. Webb NJA, Woolley RL, Lambe T, et al. Long term tapering versus standard prednisolone treatment for first episode of childhood nephrotic syndrome: phase III randomised controlled trial and economic evaluation. BMJ. 2019 May 23;365:l1800.Full text  Abstract

29. Bagga A, Mantan M. Nephrotic syndrome in children. Indian J Med Res. 2005;122:13-28. Abstract

30. Colquitt JL, Kirby J, Green C, et al. The clinical effectiveness and cost-effectiveness of treatments for children with idiopathic corticosteroid-resistant nephrotic syndrome: a systematic review. Health Technol Assess. 2007;11:iii-iv, ix-xi, 1-93. Abstract

31. Bock ME, Cohn RA, Ali FN. Treatment of childhood nephrotic syndrome with long-term, low-dose tacrolimus. Clin Nephrol. 2013;79:432-438. Abstract

32. Hamasaki Y, Yoshikawa N, Nakazato H, et al. Prospective 5-year follow-up of cyclosporine treatment in children with steroid-resistant nephrosis. Pediatr Nephrol. 2013;28:765-771. Abstract

33. Haws RM, Baum M. Efficacy of albumin and diuretic therapy in children with nephrotic syndrome. Pediatrics. 1993;91:1142-1146. Abstract

34. Palmer SC, Nand K, Strippoli GF. Interventions for minimal change disease in adults with nephrotic syndrome. Cochrane Database Syst Rev. 2008;(1):CD001537.Full text  Abstract

35. Takei I, Nitta K. Rituximab and minimal change nephrotic syndrome: a therapeutic option. Clin Exp Nephrol. 2011;15:641-647. Abstract

36. Peters HP, van de Kar NC, Wetzels JF. Rituximab in minimal change nephropathy and focal segmental glomerulosclerosis: report of four cases and review of the literature. Neth J Med. 2008;66:408-415. Abstract

37. Bruchfeld A, Benedek S, Hilderman M, et al. Rituximab for minimal change disease in adults: long-term follow-up. Nephrol Dial Transplant. 2014;29:851-856.Full text  Abstract

38. Iwabuchi Y, Takei T, Moriyama T, et al. Long-term prognosis of adult patients with steroid-dependent minimal change nephrotic syndrome following rituximab treatment. Medicine (Baltimore). 2014;93:e300.Full text  Abstract

39. Janardan J, Ooi K, Menahem S. Sustained complete remission of steroid- and cyclophosphamide-resistant minimal-change disease with a single course of rituximab therapy. Clin Kidney J. 2014;7:293-295.Full text  Abstract

40. International Study of Kidney Disease in Children. Minimal change nephrotic syndrome in children: deaths during the first 5 to 15 years' observation. Report of the International Study of Kidney Disease in Children. Pediatrics. 1984;73:497-501. Abstract

41. Bhimma R, Adhikari M, Asharam K, et al. The spectrum of chronic kidney disease (stages 2-5) in KwaZulu-Natal, South Africa. Pediatr Nephrol. 2008;23:1841-1846. Abstract

42. Ruth EM, Kemper MJ, Leumann EP, et al. Children with corticosteroid-sensitive nephrotic syndrome come of age: long-term outcome. J Pediatr. 2005;147:202-207. Abstract

43. Pais P, Avner ED. Nephrotic syndrome. In: Kliegman RM, Stanton BF, St. Geme JW III, Schor NF, Behrman RE, eds. Nelson Textbook of Pediatrics. 19th ed. Philadelphia, PA: Saunders Elsevier; 2011.

44. Nachman PH, Jennette JC, Falk RJ. Primary glomerular disease. In: Brenner BM, ed. Brenner and Rector's The Kidney. 8th ed. Philadelphia, Pa: Saunders Elsevier; 2007:30.

45. Appel GB. Glomerular disorders and nephrotic syndromes. In: Goldman L, Ausiello D, eds. Cecil Medicine. 23rd ed. Philadelphia, PA: Saunders Elsevier; 2007:122.

46. Shigidi MM. The treatment of relapse in adults with minimal change nephrotic syndrome: myths and facts. Saudi J Kidney Dis Transpl. 2011;22:10-17. Abstract

47. Renal Clinicians Group, Renal Unit, Royal Hospital for Sick Children, Yorkhill Division. Guideline for the management of nephrotic syndrome. November 2005. http://www.clinicalguidelines.scot.nhs.uk/ (last accessed 12 September 2017).Full text

48. Gillespie RS. Pediatric nephrology resources for healthcare professionals. http://kidneyweb.net (last accessed 12 September 2017).Full text